This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Congying Zhang: Innovator in Cancer Diagnosis and Treatment
Introduction
Congying Zhang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of cancer research through his innovative work on peptides. His research focuses on developing targeted therapies that can improve cancer diagnosis and treatment.
Latest Patents
Congying Zhang holds a patent for a pentapeptide associated with integrin receptor αvβ3. This pentapeptide has a specific sequence of arginine-tryptophan-arginine-asparagine-methionine. It is designed to target tumor cells that highly express the αvβ3 receptor, while sparing those that express it at lower levels and normal cells. This specificity makes the pentapeptide a valuable tool in the diagnosis and treatment of various cancers.
Career Highlights
Congying Zhang is affiliated with China Pharmaceutical University, where he conducts his research. His work has garnered attention for its potential applications in oncology. With a focus on innovative solutions, he continues to explore new avenues for cancer treatment.
Collaborations
Some of his notable coworkers include Yueqing Gu and Menglu Zhao. Their collaborative efforts contribute to the advancement of research in the field of cancer therapies.
Conclusion
Congying Zhang's innovative work in developing targeted cancer therapies highlights the importance of precision medicine. His contributions are paving the way for more effective cancer treatments and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile